| Referências bibliográficas |
| Título
do artigo: "Terapia surfactante pulmonar exógena em pediatria" |
| 1. Avery ME, Mead
J. Surface properties in relation to atelectasis and hyaline membrane
disease. Am J Dis Child 1959;97:517-23. |
 |
| 2.
Enhörning G, Robertson B. Lung expansion in the premature newborn
rabbit fetus after tracheal deposition of surfactant. Pediatrics 1972;50:55-66. |
| 3. Robertson B, Enhörning
G. The alveolar lining of the premature newborn rabbit after pharyngeal
deposition of surfactant. Lab Invest 1974;34:54-9. |
|
| 4.
Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial
surfactant therapy in hyaline-membrane disease. Lancet 1980;1:55-9. |
| 5. Greenough
A, Morley CJ, Wood S. Effect of artificial surfactant on lung function
in preterm neonates. Prog Respir Res 1984;18:263-6. |
|
| 6.
Halliday H, McClure G, Reid MMcD. Controlled trial of artificial surfactant
to prevent respiratory distress syndrome. Lancet 1984;1:476-8. |
| 7. Ten Center Study
Group. Ten centre trial of artificial surfactant in very premature
babies. BMJ 1987;294:991-6. |
|
| 8.
Enhörning G, Shennan A, Possmeyer F. Prevention of neonatal respiratory
distress syndrome by tracheal instillation of surfactant. A randomized
clinical trial. Pediatrics 1985;76:145-53. |
| 9. Halman M, Merritt
TA, Jarvenpaa A, Gluck L. Exogenous human surfactant for treatment
of severe respiratory distress syndrome. A randomized prospective
clinical trial. J Pediatr 1985;106:963-9. |
|
| 10.
Kwong M, Egan R, Notter R, Shapiro DL. Double-blind clinical trial
of calf lung surfactant extract for the prevention of hyaline membrane
disease in extremely premature infants. Pediatrics 1985;76:585-92. |
| 11. Shapiro DL, Notter
R, Morin FC, Cox C. Double-blind, randomized trial of a calf lung
surfactant extract administered at birth to very premature infants
for prevention of respiratory distress syndrome. Pediatrics 1985;76:593-9. |
|
| 12.
Wilkinson A, Jenkins P, Jeffrey JA. Two controlled trials of dry artificial
surfactant: early effects and later outcome in babies with surfactant
deficiency. Lancet 1985;2:287-91. |
| 13. Soll RF. Natural
surfactant extract treatment of RDS. In: Sinclair JL. Neonatal module
of Cochrane Database of Systematic Reviews. The Cochrane Collaboration:
Issue 1. Oxford: Update Software; 1997. |
|
| 14.
Soll RF. Synthetic surfactant treatment of RDS. In Sinclair JL. Neonatal
module of Cochrane Database of Systematic Reviews. The Cochrane Collaboration:
Issue 1. Oxford: Update software, 1997. |
| 15. Fiori RM, Diniz
EMA, Lopez JMA. Surfactant replacement therapy: a multicentric trial
comparing two dosage approaches. Acta Biomed Ateneo Parmense 1997;68:55-63. |
|
| 16.
Robertson B. Pathology and pathophysiology of neonatal surfactant
deficiency. In: Robertson B. Amsterdam, Elsevier Science Publisher;
1984. p. 384-418. |
| 17. Jobe A, Ikegami
M, Glatz T. Duration and characteristics of treatment of premature
lambs with natural surfactant. J Clin Invest 1981;67:370-5. |
|
| 18.
Fujiwara T, Robertson B. Pharmacology of exogenous surfactant. In:
Robertson B, Van Golde LMG, Batenburg JJ. Pulmonary surfactant from
molecular biology to clinical practice. Amsterdam: Elsevier Science
Publisher; 1992. p. 561-592. |
| 19. Bevilacqua
G, Parmigiani S, Robertson B and the Italian Collaborative Multicentre
Study Group. Prophylaxis of respiratory distress syndrome by treatment
with modified porcine surfactant at birth: a multicentre prospective
randomized trial. J Perinat Med 1996;24:1-12. |
|
| 20.
Dunn MS, Shennan AT, Zyack D, Possmayer F. Bovine surfactant replacement
therapy in neonates of less than 30 weeks' gestation: a randomized
controlled trial of prophylaxis vs treatment. Pediatrics 1991;87:377-86. |
| 21. Egberts J, DeWinter
JP, Sedin G, deKleine MJK, Broberger U, VanBel F, et al. Comparison
of prophylaxis and rescue treatment with Curosurf in neonates less
than 30 weeks gestation: a randomized trial. Pediatrics 1993;92:768-74. |
|
| 22.
Kattwinkel J, Bloom BT, Delmore P, Davis CL, Farrell E, Friss H, et
al. Prophylactic administration of calf lung surfactant extract is
more effective than early treatment of respiratory distress syndrome
in neonates of 29 through 32 weeks' gestation. Pediatrics 1993;92:90-8. |
| 23. Kendig JW, Notter
RH, Cox C, Reubens LJ, Davis JM, Maniscalco WM, et al. A comparison
of surfactant as immediate prophylaxis and as rescue therapy in newborns
of less than 30 weeks' gestation. N Engl J Med 1991;324:865-71. |
|
| 24.
Merritt TA, Hallman M, Berry C, Pohjavuori M, Edwards DK, Jaaskelainen
J, et al. Randomized, placebo-controlled trial of human surfactant
given at birth vs rescue administration in very low birthweight infants
with lung immaturity. J Pediatr 1991;118:581-94. |
| 25. Walti
H, Paris-Llado J, Breart G, Couchard M, and the French Collaborative
Multicentre Study Group. Porcine surfactant replacement therapy in
newborns of 25-31 weeks' gestation: a randomized multicentre trial
of prophylaxis versus rescue with multiple low doses. Acta Paediatr
1995;84(8):913-21. |
|
| 26.
Soll RF, Morley, CJ. Prophylactic versus selective use of surfactant
for preventing morbidity and mortality in preterm infants (Cochrane
Review). In: The Cochrane Library, Issue 4. Oxford: Update Software;
1999. |
| 27. Jonson B. Ventilation
patterns, surfactant and lung injury. Biol Neonate 1997;71 Suppl 1):13-17. |
|
| 28.
Pattle RE, Robards GJ, Sutherland PD. Method for demonstrating difference
between surface properties of sheep and human amniotic fluids, and
attempting to predict human respiratory distress syndrome [proceedings].
J Physiol 1976;263:110-1. |
| 29. Chida S, Fujiwara
T, Konishi M, Sasaki M. Stable microbubble test for predicting the
risk of respiratory distress syndrome: II. Prospective evaluation
of the test on amniotic fluid and gastric aspirate. Eur J Pediatr
1993;152:152-6. |
|
| 30.
Fiori HH, Varela I, Fiori RM. Stable microbubble test and click test
on gastric aspirates of preterm infants not ventilated at birth to
predict respiratory distress syndrome. Biol Neonate 2000;77(1):21.
|
| 31. Wijnberger LDE,
Huisjes AJM, Voorbij HAM, Franx A, Bruinse HW, Mol BWJ. The accuracy
of lamellar body count and lecithin/sphingomyelin ratio in the prediction
of neonatal respiratory distress syndrome: a meta-analysis. Brit J
of Obstet Gynaecol 2001;108:583-88. |
|
| 32.
Hallman M, Feldman BH, Kirkpatrick E, Gluck L. Absence of phosphatidylglycerol
(PG) in respiratory distress syndrome in the newborn. Study of the
minor surfactant phospholipids in newborns. Pediatr Res 1977;11(6):714-20.
|
| 33. Bourbon JR, Francoual
J, Magny JF, Lindenbaum A, Leluc R, Dehan M. Changes in phospholipid
composition of tracheal aspirates from newborns with hyaline membrane
disease or transient tachypnoea. Clin Chim Acta. 1990;189:87-94. |
|
| 34.
Gross TL, Sokol RJ, Kwong MS, Wilson M, Kuhnert PM. Transient tachypnea
of the newborn: the relationship to preterm delivery and significant
neonatal morbidity. Am J Obstet Gynecol 1983;146(3):236-41. |
| 35. Boo NY, Cheong
KB, Lye MS, Zulfiqar MA. Usefulness of stable microbubble test of
tracheal aspirate for diagnosis of neonatal respiratory distress syndrome.
J Paediatr Child Health 1997;33:329-34. |
|
| 36.
Sun B, Cursted T, Song GW, Robertson B. Surfactant improves lung function
and morphology in newborn rabbits with meconium aspiration. Biol Neonate
1993;63:96-104. |
| 37. Lotze A, Mitchell
BR, Bulas DI, Zola EM. Multicenter study of surfactant (beractant)
use in the treatment of term infants with severe respiratory failure.
J Pediatr 1998;132:40-7. |
|
| 38.
Diniz EMA, Fiori RM. Curosurf therapy in severe meconium aspiration
syndrome. Biol Neonate 1995;67 Suppl 1:86. |
| 39. Halliday HL,
Speer, Robertson B. Treatment of severe meconium aspiration syndrome
with porcine surfactant. Eur. J Pediatr 1996;155:1047. |
|
| 40.
Findlay RD, Taeusch HW, Walter FJ. Surfactant replacement therapy
for meconium aspiration syndrome. Pediatrics 1996;97:48-52. |
| 41. Soll
RF, Dargaville P. Surfactant for meconium aspiration syndrome in full
term infants Dates (Cochrane Review). Cochrane Database Syst Rev 2000;
(2): CD002054 Review first published: Issue 2, 2000. |
|
| 42.
Paranka MS, Walsh WF, Stancombe BB. Surfactant lavage in the piglet
model of meconium aspiration syndrome. Pediatr Res 1992;31(6):625-8. |
| 43. Balaraman V,
Meister J, Ku TL. Lavage administration of dilute surfactants after
acute lung injury in neonatal piglets. Am J Respir Crit Care Med 1998;158:12-7. |
|
| 44.
Lam BC, Yeung CY. Surfactant lavage for meconium aspiration syndrome:
a pilot study. Pediatrics 1999;103:1014-18. |
| 45. Wiswell TE, Knight
GR, Finner NN, Donn SM, Desai H, Walsh WF, Sekar KC, et al. A multicenter,
randomized, controlled trial comparing Surfaxin (Lucinactant) lavage
with standard care for treatment of meconium aspiration syndrome.
Pediatrics 2002;109(6):1081-7. |
|
| 46.
Holm BA, Enhörning G, Notter RH. A biophysical mechanism by which
plasma proteins inhibit lung surfactant activity. Chem Phys Lipids
1988;49:49-55. |
47. Holm BA, Keicher
L, Liu M. Inhibition of pulmonary surfactant function by phospholipases.
J Appl Physiol 1991;71:317-21. |
|
48.
Auten RL, Notter RH, Kendig JW. Surfactant treatment of full-term newborns
with respiratory failure. Pediatrics 1991;87:101-7. |
| 49. Fetter WPF, Baerts
W, Bos AP. Surfactant replacement therapy in neonates with respiratory
failure due to bacterial sepsis. Acta Paediatr 1995;84:14-16. |
|
| 50.
Keer MH. Surfactant protein levels in severe respiratory syncytial
virus infection. Am J Respir Crit Care Med 1999;159:1115-8. |
| 51. Dargaville PA,
South M, McDougall PN. Surfactant abnormalities in infants with severe
viral bronchiolitis. Arch Dis Child 1996;75:133-6. |
|
| 52.
Lucchetti M, Casiraghi G, Valsecchi R, Galassini E, Marraro G. Porcine-derived
surfactant treatment of severe bronchiolitis. Acta Anaest Scand 1998;42:805-10. |
| 53. Vitola LS, Piva
JP, Garcia PCR, Bruno F, Miranda AP, Martha VF. Surfactante exógeno
no tratamento da bronquiolite viral grave. J Pediatr (Rio J) 2001;77:143-7.
|
|
| 54.
Mikawa K, Maekawa N. Selective intrabronchial instillation of surfactant
in a patient with pneumonia: a preliminary report. Eur Respir J 1993;6:1563-6. |
| 55. Herting
E, Gefeller O, Robertson B, Land M, van Sorenden L, Harms K. Surfactant
treatment of neonates with respiratory failure and group B streptococcal
infection. Pediatrics 2000;106(3):957-64. |
|
| 56.
Anzueto A, Bauglman RP, Guntupallli KK. Aerosolized surfactant in
adults with sepsis-induced acute respiratory distress syndrome. N
Engl J Med 1996;334:1417-21. |
| 57. Lopez-Herce J,
de Lucas N, Carrillo A, Bustinza A, Moral R. Surfactant treatment
for acute respiratory distress syndrome. Arch Dis Child 1999;80(3):248-52. |
|
| 58.
Willson DF, Zaritsky A, Bauman LA, Dockery K, James RL, Conrad D,
et al. Instillation of calf lung surfactant extract (calfactant) is
beneficial in pediatric acute hypoxemic respiratory failure. Members
of the Mid-Atlantic Pediatric Critical Care Network. Crit Care Med
1999;27(1):188-95. |
| 59. Soll RF, Morley
CJ. Prophylactic versus selective use of surfactant in preventing
morbidity and mortality in preterm infants [review]. Cochrane Database
Syst Rev 2001;(2):CD000511. |
|
| 60.
Zola EM, Gunkel JH, Chan RK, Lim MO, Knox I, Feldman BH, et al. Comparison
of three dosing procedures for administration of bovine surfactant
to neonates with respiratory distress syndrome. J Pediatr 1993;122(3):453-9.
|
| 61. Jobe
AH. Techniques for administering surfactasnt. In: Robertson B, Taeusch
HW. Surfactant Therapy for Lung Disease. New York: Marcel Dekker Inc.;
1995. p. 309-24. |
